Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ascletis, Aum, Bluejay, Buchang, CSL Vifor, Eli Lilly, Everest Medicines, Gilead Sciences, Junshi, Mabwell, Novavax, Remd, Revive, Takeda.